Skip to main content

Novo Nordisk A/S (NYSE: NVO) Investor Securities Class Action Lawsuit 01/24/2025

  • If you purchased a significant amount of shares of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 to December 19, 2024, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 25, 2025. NYSE: NVO investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

July 28, 2026 - The court denied in part and granted in part the defendants motion to dismiss the case. December 22, 2025 -  The defendants filed their motion to dismiss the case. January 24, 2025 - An investor in shares of Novo Nordisk A/S (NYSE: NVO) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by Novo N...



You must register (for free) or login to view the entire case.